These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 25474865

  • 1. Evaluation of the stability of ketoprofen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF, Sauvageot J, Addo RT.
    Int J Pharm Compd; 2014; 18(4):348-50. PubMed ID: 25474865
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the stability of promethazine hydrochloride in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF, Sauvageot J.
    Int J Pharm Compd; 2014; 18(4):345-7. PubMed ID: 25474864
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the stability of fluoxetine in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF, Sauvageot J.
    Int J Pharm Compd; 2014; 18(3):253-5. PubMed ID: 25306774
    [Abstract] [Full Text] [Related]

  • 4. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH, Bonam SP, Wei Y, Alexander K.
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the stability of acetaminophen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF, Sauvageot J.
    Int J Pharm Compd; 2012; 16(5):428-30. PubMed ID: 23072202
    [Abstract] [Full Text] [Related]

  • 6. Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
    Gorman G, Sokom S, Coward L, Arnold JJ.
    Int J Pharm Compd; 2017; 21(2):164-170. PubMed ID: 28346213
    [Abstract] [Full Text] [Related]

  • 7. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
    Hong EJ, Sumanasekera W, Le UM.
    Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
    [Abstract] [Full Text] [Related]

  • 8. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V, Gupta S, Saini V.
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [Abstract] [Full Text] [Related]

  • 9. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M, Belgamwar V, Gattani S, Surana S, Tekade A.
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [Abstract] [Full Text] [Related]

  • 10. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
    Nornoo AO, Wulz J, Yoon H, Nan Y, Lese M.
    Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
    [Abstract] [Full Text] [Related]

  • 11. In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester.
    McKinney RD, Dunbar JR.
    Int J Pharm Compd; 2021 Mar; 25(3):241-245. PubMed ID: 34125715
    [Abstract] [Full Text] [Related]

  • 12. Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan.
    Agrawal V, Gupta V, Ramteke S, Trivedi P.
    AAPS PharmSciTech; 2010 Dec; 11(4):1718-25. PubMed ID: 21128126
    [Abstract] [Full Text] [Related]

  • 13. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream.
    Lehman PA, Raney SG.
    Int J Pharm Compd; 2012 Dec; 16(3):248-52. PubMed ID: 23050302
    [Abstract] [Full Text] [Related]

  • 14. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil.
    Richards H, Thomas CP, Bowen JL, Heard CM.
    J Pharm Pharmacol; 2006 Jul; 58(7):903-8. PubMed ID: 16805949
    [Abstract] [Full Text] [Related]

  • 15. Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel.
    Dowling TC, Arjomand M, Lin ET, Allen LV, McPherson ML.
    Am J Health Syst Pharm; 2004 Dec 01; 61(23):2541-4. PubMed ID: 15595229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Propolis organogel as a novel topical delivery system for treating wounds.
    Balata G, El Nahas HM, Radwan S.
    Drug Deliv; 2014 Feb 01; 21(1):55-61. PubMed ID: 24295500
    [Abstract] [Full Text] [Related]

  • 18. The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
    Bramwell BL, Williams LA.
    Int J Pharm Compd; 2012 Feb 01; 16(1):62-3. PubMed ID: 23050314
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date.
    Pignato A, Pankaskie M, Birnie C.
    Int J Pharm Compd; 2010 Feb 01; 14(6):522-5. PubMed ID: 23965656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.